The treatment of tumors is important, as anyone in the field of brain cancer research can tell you. You want to be able to differentiate the healthy cells from those which are not nearly as healthy. Of course, this means that certain substances and tools will have to be put to use but which ones can prove themselves as the most effective, you may wonder? A certain drug came to my attention after reading a report and it seems to contain quite a bit of potential, too.
Brain cancer research is easily one of the greatest fields of research to consider. There are so many details to take into account, whether it is a matter of the number of potential drugs that can be put to use or what have you. When it comes to surgery, many will tell you that there is a level of risk to be aware of, especially when given the rate of success from one patient to the next. New approaches will be focused on by various organizations, Voices against Brain Cancer included.
YottaFire posted an article that spoke about a particular drug by the name of J101. For those who do not know, this drug - focused on by Cancer Research UK specialists - is one that is able to halt the progression of cancerous cells without bringing any harm to the healthy ones. It is clear that this level of success is a great one and the details go to show it. Of course, you are probably wondering about the specific details related to the actions of J101.
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
I do not think that anyone can argue with the level of attention brought to the field that entails brain cancer approaches. Certain drugs will be focused on more so than others and the ones that seem to differentiate between healthy and unhealthy cells are undeniably vital. When it comes to this type of cancer, it's hard to argue just how important they are. In time, I am sure that the level of potential seen here is going to be put into effect in the long run.
Brain cancer research is easily one of the greatest fields of research to consider. There are so many details to take into account, whether it is a matter of the number of potential drugs that can be put to use or what have you. When it comes to surgery, many will tell you that there is a level of risk to be aware of, especially when given the rate of success from one patient to the next. New approaches will be focused on by various organizations, Voices against Brain Cancer included.
YottaFire posted an article that spoke about a particular drug by the name of J101. For those who do not know, this drug - focused on by Cancer Research UK specialists - is one that is able to halt the progression of cancerous cells without bringing any harm to the healthy ones. It is clear that this level of success is a great one and the details go to show it. Of course, you are probably wondering about the specific details related to the actions of J101.
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
I do not think that anyone can argue with the level of attention brought to the field that entails brain cancer approaches. Certain drugs will be focused on more so than others and the ones that seem to differentiate between healthy and unhealthy cells are undeniably vital. When it comes to this type of cancer, it's hard to argue just how important they are. In time, I am sure that the level of potential seen here is going to be put into effect in the long run.
About the Author:
For more knowledge about brain cancer research and awareness overall, please consult Voices against Brain Cancer
No comments:
Post a Comment